- Home
- CLIR vs NRSN Comparison
CLIR vs NRSN Comparison
Compare CLIR & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLIR
- NRSN
- Stock Information
- Founded
- CLIR 2008
- NRSN 2017
- Country
- CLIR United States
- NRSN Israel
- Employees
- CLIR N/A
- NRSN N/A
- Industry
- CLIR Industrial Machinery/Components
- NRSN Biotechnology: Pharmaceutical Preparations
- Sector
- CLIR Industrials
- NRSN Health Care
- Exchange
- CLIR Nasdaq
- NRSN Nasdaq
- Market Cap
- CLIR 30.7M
- NRSN 26.0M
- IPO Year
- CLIR 2012
- NRSN 2021
- Fundamental
- Price
- CLIR $0.51
- NRSN $1.18
- Analyst Decision
- CLIR Strong Buy
- NRSN Buy
- Analyst Count
- CLIR 1
- NRSN 2
- Target Price
- CLIR $2.00
- NRSN $14.00
- AVG Volume (30 Days)
- CLIR 89.1K
- NRSN 1.4M
- Earning Date
- CLIR 11-13-2025
- NRSN 09-17-2025
- Dividend Yield
- CLIR N/A
- NRSN N/A
- EPS Growth
- CLIR N/A
- NRSN N/A
- EPS
- CLIR N/A
- NRSN N/A
- Revenue
- CLIR $2,983,000.00
- NRSN N/A
- Revenue This Year
- CLIR $13.13
- NRSN N/A
- Revenue Next Year
- CLIR $143.88
- NRSN N/A
- P/E Ratio
- CLIR N/A
- NRSN N/A
- Revenue Growth
- CLIR 19.03
- NRSN N/A
- 52 Week Low
- CLIR $0.46
- NRSN $0.80
- 52 Week High
- CLIR $1.72
- NRSN $2.60
- Technical
- Relative Strength Index (RSI)
- CLIR 34.97
- NRSN 46.42
- Support Level
- CLIR $0.46
- NRSN $1.14
- Resistance Level
- CLIR $0.57
- NRSN $1.28
- Average True Range (ATR)
- CLIR 0.03
- NRSN 0.15
- MACD
- CLIR -0.01
- NRSN 0.03
- Stochastic Oscillator
- CLIR 31.80
- NRSN 22.33
About CLIR ClearSign Technologies Corporation (DE)
ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.